Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription


2 AJR Am J Roentgenol
1 Am J Clin Oncol
2 Am J Surg Pathol
1 Ann Oncol
37 Ann Surg Oncol
1 Anticancer Res
8 BMC Cancer
3 Br J Cancer
2 Breast Cancer
2 Breast Cancer Res
5 Breast Cancer Res Treat
5 Cancer Res
1 Clin Breast Cancer
1 Eur J Cancer
2 Eur J Surg Oncol
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Nucl Med
1 Mod Pathol
3 NPJ Breast Cancer
2 Oncogene
2 Oncol Rep
1 Oncology (Williston Park)
5 PLoS One
2 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. NIELL BL, Augusto B, McIntyre M, Conley CC, et al
    Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    AJR Am J Roentgenol. 2021 May 12:1-8. doi: 10.2214/AJR.20.23333.
    PubMed         Abstract available

  2. CHOU SS, Baikpour M, Zhang W, Mercaldo SF, et al
    Shear-Wave Elastography of the Breast: Impact of Technical Image Quality Parameters on Diagnostic Accuracy.
    AJR Am J Roentgenol. 2021;216:1205-1215.
    PubMed         Abstract available

    Am J Clin Oncol

  3. KIM K, Shim SR, Kim SJ
    Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer: A Bayesian Network Meta-analysis.
    Am J Clin Oncol. 2021 May 12. pii: 00000421-900000000-98566.
    PubMed         Abstract available

    Am J Surg Pathol

  4. MACCOLL CE, Pare G, Salehi A, Hodgson N, et al
    Postneoadjuvant Pure and Predominantly Pure Intralymphatic Breast Carcinoma: Case Series and Literature Review.
    Am J Surg Pathol. 2021;45:537-542.
    PubMed         Abstract available

  5. KUSAFUKA K, Yamada H, Ishino K, Maeda M, et al
    Salivary Duct Carcinoma With Rhabdoid Features-No or Aberrant Expression of E-cadherin and Genetic Changes in CDH1: Immunohistochemical and Genetic Analyses of 17 Cases.
    Am J Surg Pathol. 2021;45:439-449.
    PubMed         Abstract available

    Ann Oncol

  6. GAO JJ, Krol D, Narayan P, Cardoso F, et al
    Bringing Safe and Effective Therapies to Premenopausal Women with Breast Cancer: Efforts to Broaden Eligibility Criteria.
    Ann Oncol. 2021 May 12. pii: S0923-7534(21)01556.

    Ann Surg Oncol

  7. UZAN C, Mazouni C, Rossoni C, De Korvin B, et al
    Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions.
    Ann Surg Oncol. 2021;28:2138-2145.
    PubMed         Abstract available

  8. TAMBURRINO D, Guarneri G, Capurso G, Falconi M, et al
    ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2323-2324.

  9. CROWN A, Rocha FG, Grumley J
    ASO Author Reflections: Oncoplastic Surgery Facilitates Breast Conservation and May Permit More Judicious Chemotherapy Use.
    Ann Surg Oncol. 2021;28:2210-2211.

  10. LEE KT, Bae J, Jeon BJ, Pyon JK, et al
    Adjuvant Chemotherapy in Two-Stage Tissue Expander/Implant Breast Reconstruction: Does it Affect Final Outcomes?
    Ann Surg Oncol. 2021;28:2191-2198.
    PubMed         Abstract available

  11. HELLER DR, Zhuo H, Zhang Y, Parikh N, et al
    Surgical Outcomes of Mastectomy with Immediate Autologous Reconstruction Followed by Radiation.
    Ann Surg Oncol. 2021;28:2169-2179.
    PubMed         Abstract available

  12. CROWN A, Handy N, Weed C, Laskin R, et al
    Oncoplastic Breast-Conserving Surgery: Can We Reduce Rates of Mastectomy and Chemotherapy Use in Patients with Traditional Indications for Mastectomy?
    Ann Surg Oncol. 2021;28:2199-2209.
    PubMed         Abstract available

  13. SROUR MK, Kim S, Amersi F, Giuliano AE, et al
    Comparison of Multiple Wire, Radioactive Seed, and Savi Scout((R)) Radar Localizations for Management of Surgical Breast Disease.
    Ann Surg Oncol. 2021;28:2212-2218.
    PubMed         Abstract available

  14. CHU CK, Butler CE
    How Much Flap to Take? Invited Commentary on "Comparisons Between Normal Body Mass Index and Overweight Patients Who Underwent Unilateral Microsurgical Breast Reconstructions".
    Ann Surg Oncol. 2021;28:22-23.

  15. TAMBURRINO D, Guarneri G, Pagnanelli M, Crippa S, et al
    Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence?
    Ann Surg Oncol. 2021;28:2312-2322.
    PubMed         Abstract available

  16. HELLER DR, Avraham T, Lannin DR, Killelea BK, et al
    ASO Author Reflections: An Evolving Approach to Autologous Reconstruction in the Setting of Postmastectomy Radiation.
    Ann Surg Oncol. 2021;28:2180-2181.

  17. ELMORE LC, Dietz JR, Myckatyn TM, Margenthaler JA, et al
    The Landmark Series: Mastectomy Trials (Skin-Sparing and Nipple-Sparing and Reconstruction Landmark Trials).
    Ann Surg Oncol. 2021;28:273-280.
    PubMed         Abstract available

  18. MAMTANI A, Romanoff A, Baser R, Vincent A, et al
    Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?
    Ann Surg Oncol. 2021;28:295-302.
    PubMed         Abstract available

  19. PETRUOLO O, Sevilimedu V, Montagna G, Le T, et al
    How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?
    Ann Surg Oncol. 2021;28:287-294.
    PubMed         Abstract available

  20. BALISKI C, Hughes L, Bakos B
    Lowering Re-excision Rates After Breast-Conserving Surgery: Unraveling the Intersection Between Surgeon Case Volumes and Techniques.
    Ann Surg Oncol. 2021;28:894-901.
    PubMed         Abstract available

  21. MURPHY BL, Jakub JW, Asaad M, Day CN, et al
    Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients: When to Stop?
    Ann Surg Oncol. 2021;28:888-893.
    PubMed         Abstract available

  22. CHENG MH, Koide S, Chen C, Lin YL, et al
    Comparisons Between Normal Body Mass Index and Overweight Patients Who Underwent Unilateral Microsurgical Breast Reconstructions.
    Ann Surg Oncol. 2021;28:353-362.
    PubMed         Abstract available

  23. HE H, Whitman GJ, Moseley T
    ASO Author Reflections: Management of Benign Breast Intraductal Papillomas Without Atypia Diagnosed at Imaging-Guided Biopsies.
    Ann Surg Oncol. 2021;28:1356-1357.

  24. CROWN A, Morrow M
    ASO Author Reflections: Residual Disease in the Breast After Neoadjuvant Chemotherapy Does Not Mandate Routine Post-Mastectomy Radiation Therapy/Regional Nodal Irradiation.
    Ann Surg Oncol. 2021;28:1336-1337.

  25. SON JD, Piper M, Hewitt K, Alvarado M, et al
    Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.
    Ann Surg Oncol. 2021;28:2555-2560.
    PubMed         Abstract available

  26. NAKHLIS F, Baker GM, Pilewskie M, Gelman R, et al
    The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
    Ann Surg Oncol. 2021;28:2573-2578.
    PubMed         Abstract available

  27. SATYANANDA V, Oshi M, Endo I, Takabe K, et al
    High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
    Ann Surg Oncol. 2021 May 8. pii: 10.1245/s10434-021-10063.
    PubMed         Abstract available

  28. SATYANANDA V, Oshi M, Endo I, Takabe K, et al
    ASO Author Reflections: High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
    Ann Surg Oncol. 2021 May 8. pii: 10.1245/s10434-021-10135.

  29. LAI HW, Chen ST, Liao CY, Mok CW, et al
    Oncologic Outcome of Endoscopic Assisted Breast Surgery Compared with Conventional Approach in Breast Cancer: An Analysis of 3426 Primary Operable Breast Cancer Patients from Single Institute with and Without Propensity Score Matching.
    Ann Surg Oncol. 2021 May 11. pii: 10.1245/s10434-021-09950.
    PubMed         Abstract available

  30. VAN DER NOORDAA MEM, Ioan I, Rutgers EJ, van Werkhoven E, et al
    Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience.
    Ann Surg Oncol. 2021 May 12. pii: 10.1245/s10434-021-09865.
    PubMed         Abstract available

  31. SHOWALTER SL, Meneveau MO, Keim-Malpass J, Camacho TF, et al
    Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2021 May 12. pii: 10.1245/s10434-021-10064.
    PubMed         Abstract available

  32. GOMMERS JJJ, Duijm LEM, Bult P, Strobbe LJA, et al
    ASO Visual Abstract: The Impact of Preoperative Breast MRI on Surgical Margin Status in Breast Cancer Patients Recalled at Biennial Screening Mammography: An Observational Cohort Study.
    Ann Surg Oncol. 2021 May 13. pii: 10.1245/s10434-021-10001.

  33. SHOWALTER SL, Meneveau MO, Keim-Malpass J, Camacho TF, et al
    ASO Visual Abstract: Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women With Early-Stage Breast Cancer.
    Ann Surg Oncol. 2021 May 14. pii: 10.1245/s10434-021-10096.

  34. ANGARITA S, DiNome M
    ASO Author Reflections: Moving the Ball Forward Toward De-Escalation of Axillary Surgery for Patients with Clinically Node-Positive Disease.
    Ann Surg Oncol. 2021;28:2619-2620.

  35. BAKER JL, Dizon DS, Wenziger CM, Streja E, et al
    ASO Visual Abstract: "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey.
    Ann Surg Oncol. 2021;28:2507.
    PubMed         Abstract available

  36. VANE MLG, Hunter-Squires J, Kim S, Smidt ML, et al
    Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy.
    Ann Surg Oncol. 2021;28:2522-2528.
    PubMed         Abstract available

  37. LAW W, Look Hong N, Ravi A, Wright FC, et al
    ASO Author Reflections: Which Preoperative Breast Localization Method is More Economical: Radioactive Seed or Wire-Guided Localization?
    Ann Surg Oncol. 2021;28:1379-1380.

  38. DE ROOIJ L, van Kuijk SMJ, Granzier RWY, Hintzen KFH, et al
    Reducing Seroma Formation and Its Sequelae After Mastectomy by Closure of the Dead Space: A Multi-center, Double-Blind Randomized Controlled Trial (SAM-Trial).
    Ann Surg Oncol. 2021;28:2599-2608.
    PubMed         Abstract available

  39. BAKER JL, Dizon DS, Wenziger CM, Streja E, et al
    "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey.
    Ann Surg Oncol. 2021;28:2493-2505.
    PubMed         Abstract available

  40. BAKER JL, Attai DJ
    ASO Author Reflections: Patients Who Go Flat After Mastectomy Deserve an Aesthetic Flat Closure.
    Ann Surg Oncol. 2021;28:2506.

  41. GILMORE RC, Wang P, Kaczmarski K, Hutfless S, et al
    Underutilization of Needle Biopsy Before Breast Surgery: A Measure of Low-Value Care.
    Ann Surg Oncol. 2021;28:2485-2492.
    PubMed         Abstract available

  42. MARGENTHALER JA, Dietz JR, Chatterjee A
    The Landmark Series: Breast Conservation Trials (including oncoplastic breast surgery).
    Ann Surg Oncol. 2021;28:2120-2127.
    PubMed         Abstract available

  43. JOHNSON JE, Ollila DW, Boughey JC
    Surgical Options in Management of the Breast and Axilla: Independent Choices?
    Ann Surg Oncol. 2021;28:2421-2424.

    Anticancer Res

  44. GUSHO CA, Blank AT
    What Is the Clinical Impact of Sending Tissue for Histopathology During Surgery for Known, Diffuse Metastatic Disease to Bone?
    Anticancer Res. 2021;41:2473-2476.
    PubMed         Abstract available

    BMC Cancer

  45. WANG Y, Wang Y, Chen R, Tang Z, et al
    Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients.
    BMC Cancer. 2021;21:542.
    PubMed         Abstract available

  46. SOOD R, Masalu N, Connolly RM, Chao CA, et al
    Invasive breast Cancer treatment in Tanzania: landscape assessment to prepare for implementation of standardized treatment guidelines.
    BMC Cancer. 2021;21:527.
    PubMed         Abstract available

  47. WANG B, Wang H, Zhao A, Zhang M, et al
    Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
    BMC Cancer. 2021;21:523.
    PubMed         Abstract available

  48. HUANG CC, Tsai YF, Liu CY, Chao TC, et al
    Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.
    BMC Cancer. 2021;21:199.
    PubMed         Abstract available

  49. THUREAU S, Marchesi V, Vieillard MH, Perrier L, et al
    Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase II
    BMC Cancer. 2021;21:117.
    PubMed         Abstract available

  50. HERNANDEZ VARGAS JA, Ramirez Barbosa PX, Gil Quijano AM, Valbuena AM, et al
    Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis.
    BMC Cancer. 2020;20:1097.
    PubMed         Abstract available

  51. REZNICZEK GA, Giger-Pabst U, Thaher O, Tempfer CB, et al
    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer.
    BMC Cancer. 2020;20:1122.
    PubMed         Abstract available

  52. KAWAMOTO T, Shikama N, Kurokawa C, Hara N, et al
    A prospective feasibility study of a 1-mm bolus for postmastectomy radiotherapy.
    BMC Cancer. 2021;21:109.
    PubMed         Abstract available

    Br J Cancer

  53. ROBERTO A, Colombo C, Candiani G, Satolli R, et al
    Correction: A dynamic web-based decision aid to improve informed choice in organised breast cancer screening. A pragmatic randomized trial in Italy.
    Br J Cancer. 2021 May 11. pii: 10.1038/s41416-021-01437.

  54. RING A, Battisti NML, Reed MWR, Herbert E, et al
    Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.
    Br J Cancer. 2021 May 10. pii: 10.1038/s41416-021-01388.
    PubMed         Abstract available

  55. KREGTING LM, Kaljouw S, de Jonge L, Jansen EEL, et al
    Effects of cancer screening restart strategies after COVID-19 disruption.
    Br J Cancer. 2021;124:1516-1523.
    PubMed         Abstract available

    Breast Cancer

  56. CHEN XQ, Zhang F, Xiao FH, Peng Y, et al
    Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
    Breast Cancer. 2021 May 8. pii: 10.1007/s12282-021-01262.
    PubMed         Abstract available

  57. PEARSON A, Dhillon HM, Kiely BE
    Genitourinary symptoms in women with breast cancer: what do oncology health professionals think and do about them?
    Breast Cancer. 2021 May 11. pii: 10.1007/s12282-021-01260.
    PubMed         Abstract available

    Breast Cancer Res

  58. AL-ZAHRANI KN, Abou-Hamad J, Pascoal J, Labreche C, et al
    AKT-mediated phosphorylation of Sox9 induces Sox10 transcription in a murine model of HER2-positive breast cancer.
    Breast Cancer Res. 2021;23:55.
    PubMed         Abstract available

  59. LAINE M, Fanning SW, Chang YF, Green B, et al
    Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.
    Breast Cancer Res. 2021;23:54.
    PubMed         Abstract available

    Breast Cancer Res Treat

  60. WATANABE J, Mitsuya K, Nakamoto S, Harada H, et al
    Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period.
    Breast Cancer Res Treat. 2021 May 8. pii: 10.1007/s10549-021-06246.
    PubMed         Abstract available

  61. ZHU Q, Ademuyiwa FO, Young C, Appleton C, et al
    Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography.
    Breast Cancer Res Treat. 2021 May 10. pii: 10.1007/s10549-021-06239.
    PubMed         Abstract available

  62. ARJMANDI F, Mootz A, Farr D, Reddy S, et al
    New horizons in imaging and surgical assessment of breast cancer lymph node metastasis.
    Breast Cancer Res Treat. 2021 May 12. pii: 10.1007/s10549-021-06248.
    PubMed         Abstract available

  63. EUSTACE AJ, Madden SF, Fay J, Collins DM, et al
    The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer.
    Breast Cancer Res Treat. 2021 May 13. pii: 10.1007/s10549-021-06244.
    PubMed         Abstract available

  64. CHUN JW, Kim J, Chung IIY, Ko BS, et al
    Comparison of survival outcomes for axillary surgery extent based on intraoperative sentinel lymph node biopsy result after neoadjuvant chemotherapy for breast cancer.
    Breast Cancer Res Treat. 2021 May 8. pii: 10.1007/s10549-021-06249.
    PubMed         Abstract available

    Cancer Res

  65. HAPACH LA, Carey SP, Schwager SC, Taufalele PV, et al
    Phenotypic heterogeneity and metastasis of breast cancer cells.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-1799.
    PubMed         Abstract available

  66. SHAN P, Yang F, Qi H, Hu Y, et al
    Alteration of MDM2 by the small molecule YF438 exerts anti-tumor effects in triple-negative breast cancer.
    Cancer Res. 2021 May 13. pii: 0008-5472.CAN-20-0922.
    PubMed         Abstract available

  67. GUO Q, Bartish M, Goncalves C, Huang F, et al
    The MNK1/2-eIF4E axis supports immune suppression and metastasis in postpartum breast cancer.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-3143.
    PubMed         Abstract available

  68. LEE S, Amgad M, Mobadersany P, McCormick M, et al
    Interactive Classification of Whole-Slide Imaging Data for Cancer Researchers.
    Cancer Res. 2021;81:1171-1177.
    PubMed         Abstract available

  69. KARLSSON T, Johansson T, Hoglund J, Ek WE, et al
    Time-dependent effects of oral contraceptive use on breast, ovarian and endometrial cancers.
    Cancer Res. 2020 Dec 17. pii: 0008-5472.CAN-20-2476.
    PubMed         Abstract available

    Clin Breast Cancer

  70. ECE SOLMAZ A, Yeniay L, Gokmen E, Zekioglu O, et al
    Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer.
    Clin Breast Cancer. 2021 Apr 12. pii: S1526-8209(21)00070.
    PubMed         Abstract available

    Eur J Cancer

  71. LUFTNER D, Tesch H, Schmidt M, Hartkopf AD, et al
    Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study.
    Eur J Cancer. 2021;150:268-277.
    PubMed         Abstract available

    Eur J Surg Oncol

  72. CANAVESE G, Tinterri C, Carli F, Garrone E, et al
    Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.
    Eur J Surg Oncol. 2021 May 3. pii: S0748-7983(21)00471.
    PubMed         Abstract available

  73. DE LUCA A, Frusone F, Buzzacchino F, Amabile MI, et al
    First Surgical National Consensus Conference of the Italian Breast Surgeons association (ANISC) on breast cancer management in neoadjuvant setting: Results and summary.
    Eur J Surg Oncol. 2021 May 3. pii: S0748-7983(21)00469.
    PubMed         Abstract available

    Int J Cancer

  74. LILLEBORGE M, Falk RS, Sorlie T, Ursin G, et al
    Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion.
    Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33680.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  75. GERBER NK, Shao H, Chadha M, Deb P, et al
    Radiation without endocrine therapy in older women with stage I estrogen-receptor (ER) positive breast cancer is not associated with a higher risk of second breast cancer events.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00457.
    PubMed         Abstract available

    J Nucl Med

  76. BOERS J, Loudini N, Brunsch CL, Koza SA, et al
    Value of (18)F-FES-PET to solve clinical dilemmas in breast cancer patients: a retrospective study.
    J Nucl Med. 2021 May 14. pii: jnumed.120.256826. doi: 10.2967/jnumed.120.256826.
    PubMed         Abstract available

    Mod Pathol

  77. POLONIA A, Caramelo A
    HER2 in situ hybridization test in breast cancer: quantifying margins of error and genetic heterogeneity.
    Mod Pathol. 2021 May 12. pii: 10.1038/s41379-021-00813.
    PubMed         Abstract available

    NPJ Breast Cancer

  78. LI N, Zethoven M, McInerny S, Devereux L, et al
    Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.
    NPJ Breast Cancer. 2021;7:52.
    PubMed         Abstract available

  79. STANTON SE, Gad E, Ramos E, Corulli L, et al
    Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients.
    NPJ Breast Cancer. 2021;7:50.
    PubMed         Abstract available

  80. PUKLIN L, Cartmel B, Harrigan M, Lu L, et al
    Randomized trial of weight loss on circulating ghrelin levels among breast cancer survivors.
    NPJ Breast Cancer. 2021;7:49.
    PubMed         Abstract available


  81. LAGER TW, Conner C, Keating CR, Warshaw JN, et al
    Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01821.
    PubMed         Abstract available

  82. XU Q, Zhang J, Telfer BA, Zhang H, et al
    The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01798.
    PubMed         Abstract available

    Oncol Rep

  83. LEE KS, Lee MG, Nam KS
    Evaluation of the antimetastatic and anticancer activities of morin in HER2overexpressing breast cancer SKBR3 cells.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  84. WANG CP, Yu YZ, Zhao H, Xie LJ, et al
    MicroRNA4545p promotes breast cancer progression by inducing epithelialmesenchymal transition via targeting the FoxJ2/Ecadherin axis.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

    Oncology (Williston Park)

  85. NAGAYAMA A, Vidula N, Bardia A
    Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates.
    Oncology (Williston Park). 2021;35:249-254.
    PubMed         Abstract available

    PLoS One

  86. YAMAMURO M, Asai Y, Hashimoto N, Yasuda N, et al
    The effect of breast density on the missed lesion rate in screening digital mammography determined using an adjustable-density breast phantom tailored to Japanese women.
    PLoS One. 2021;16:e0245060.
    PubMed         Abstract available

  87. PILLAI SG, Siddappa CM, Ma C, Snider J, et al
    A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
    PLoS One. 2021;16:e0246139.
    PubMed         Abstract available

  88. SAKATA-MATSUZAWA M, Denda-Nagai K, Fujihira H, Noji M, et al
    Glycans unique to the relapse-prone subset within triple-negative breast cancer as revealed by lectin array-based analysis of surgical specimens.
    PLoS One. 2021;16:e0250747.
    PubMed         Abstract available

  89. CHA YJ, Kim D, Bae SJ, Ahn SG, et al
    The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
    PLoS One. 2021;16:e0250986.
    PubMed         Abstract available

  90. RAGO M, Placidi L, Polsoni M, Rambaldi G, et al
    Evaluation of a generalized knowledge-based planning performance for VMAT irradiation of breast and locoregional lymph nodes-Internal mammary and/or supraclavicular regions.
    PLoS One. 2021;16:e0245305.
    PubMed         Abstract available


    Interval Breast Cancer after Digital Breast Tomosynthesis-based Screening: A Glimmer of Hope.
    Radiology. 2021 May 11:210179. doi: 10.1148/radiol.2021210179.

  92. HOFVIND S, Moshina N, Holen AS, Danielsen AS, et al
    Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening.
    Radiology. 2021 May 11:203936. doi: 10.1148/radiol.2021203936.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.